Your browser doesn't support javascript.
loading
Susceptibility of Helicobacter pylori to Levofloxacin and Rifampicin in Israel.
Peretz, Avi; Paritsky, Maya; Dinisman-Zavulunov, Eleonora; Pastukh, Nina; Glyatman, Tatyana; On, Avi.
Afiliación
  • Peretz A; 1 Clinical Microbiology Laboratory, Baruch Padeh Medical Center, Poriya, Affiliated with the Faculty of Medicine, Bar Ilan University , Galilee, Israel .
  • Paritsky M; 2 Gastrointestinal Unit, Baruch Padeh Medical Center, Poriya, Affiliated with the Faculty of Medicine, Bar Ilan University , Galilee, Israel .
  • Dinisman-Zavulunov E; 3 Pharmacy Services, Baruch Padeh Medical Center, Poriya, Affiliated with the Faculty of Medicine, Bar Ilan University , Galilee, Israel .
  • Pastukh N; 1 Clinical Microbiology Laboratory, Baruch Padeh Medical Center, Poriya, Affiliated with the Faculty of Medicine, Bar Ilan University , Galilee, Israel .
  • Glyatman T; 1 Clinical Microbiology Laboratory, Baruch Padeh Medical Center, Poriya, Affiliated with the Faculty of Medicine, Bar Ilan University , Galilee, Israel .
  • On A; 4 Pediatric Gastrointestinal Unit, Baruch Padeh Medical Center, Poriya, Affiliated with the Faculty of Medicine, Bar Ilan University , Galilee, Israel .
Microb Drug Resist ; 21(4): 448-51, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25793253
The aim of this study was to assess the resistance level of Helicobacter pylori to levofloxacin and rifampicin from samples collected from pediatric and adult Israeli patients from 2012 to 2013. A total of 117 isolate samples of H. pylori were collected between 2012 and 2013. Isolates were cultured from stomach antrum biopsies and identified by the microbiology laboratory. Isolates were considered susceptible to levofloxacin and rifampicin by an Etest. Out of 117 isolates, 105 were found susceptible and 12 resistant to levofloxacin. For rifampicin, 104 isolates were susceptible and 13 were resistant. Study results estimate an alarming resistance rate, which reiterates the need for prudent use of alternative antibiotics to prevent further spread of resistant strains. Therefore, we suggest subjecting cultures from biopsy samples to susceptibility testing for the purpose of identification of strains resistant to levofloxacin and rifampicin among other antibiotic agents. This will allow for successful monitoring of microbial resistance and will assure prudent use of antimicrobial modalities.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Helicobacter pylori / Levofloxacino / Antibacterianos Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Microb Drug Resist Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2015 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Helicobacter pylori / Levofloxacino / Antibacterianos Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Microb Drug Resist Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2015 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos